4.7 Article

Extracellular vesicle-transmitted miR-671-5p alleviates lung inflammation and injury by regulating the AAK1/NF-KB axis

Related references

Note: Only part of the references are listed.
Article Cell Biology

Exosomes from adipose-derived mesenchymal stem cells alleviate sepsis-induced lung injury in mice by inhibiting the secretion of IL-27 in macrophages

Xiaoyan Wang et al.

Summary: The study found that exosomes from adipose-derived MSCs (ADMSCs) have anti-inflammatory effects in sepsis-induced acute lung injury by inhibiting IL-27 secretion and reducing the release of inflammatory cytokines, thereby improving the survival rate of mice.

CELL DEATH DISCOVERY (2022)

Article Engineering, Biomedical

TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis

Ziyu Yu et al.

Summary: This study investigates the potential therapeutic pathway for neuroprotection against retinal ischemia-reperfusion injury (IRI) using gingival mesenchymal stem cell (GMSC) exosomes stimulated by TNF-alpha. The results suggest that TG-exos can alleviate inflammation and cell loss in the IRI mouse model. Furthermore, miR-21-5p enriched in TG-exos plays a crucial role in neuroprotection and anti-inflammation by targeting the MEG3/miR-21-5p/PDCD4 axis.

BIOMATERIALS (2022)

Article Cell Biology

Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth

Minghui Cao et al.

Summary: Breast cancer-derived extracellular vesicles suppress pancreatic insulin secretion, leading to dysregulated glucose homeostasis and enhanced tumor growth by targeting PKM in beta-cells.

NATURE CELL BIOLOGY (2022)

Article Biotechnology & Applied Microbiology

MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's disease

Marta Esteves et al.

Summary: This study utilized umbilical cord blood mononuclear cell-derived extracellular vesicles as a biological carrier for delivering miR-124-3p, showing therapeutic effects in a mouse model of Parkinson's disease. The findings suggest that miR-124-3p-loaded small extracellular vesicles have the potential to protect dopaminergic neurons and counteract motor behavior symptoms.

MOLECULAR THERAPY (2022)

Review Pharmacology & Pharmacy

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19

Faheem Hyder Pottoo et al.

Summary: Coronaviruses are a type of non-segmented, single-stranded positive-sense RNA viruses, with 6 human coronaviruses identified so far, including the novel coronavirus SARS-CoV-2. Infection with SARS-CoV-2 may lead to cytokine storm, causing a series of diseases and death. Efforts to reduce cytokine storm are being considered as a new approach to combat COVID-19 mortality.

SAUDI PHARMACEUTICAL JOURNAL (2021)

Article Multidisciplinary Sciences

Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation

Christopher M. Bobba et al.

Summary: Mechanical ventilation exacerbates lung injury, and miR-146a is a mechanosensitive microRNA that can be used to mitigate lung injury. The study found that overexpressing miR-146a using a nanoparticle delivery platform is an effective strategy for preventing injury.

NATURE COMMUNICATIONS (2021)

Article Cell & Tissue Engineering

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles ameliorate airway inflammation in a rat model of chronic obstructive pulmonary disease (COPD)

Noridzzaida Ridzuan et al.

Summary: This study demonstrated the potential anti-inflammatory effects of human umbilical cord mesenchymal stem cell (hUC-MSC)-derived extracellular vesicles (EVs) in a rat model of COPD. Both hUC-MSCs and EVs were found to effectively ameliorate COPD-induced inflammation, suggesting that EVs could serve as a new cell-free-based therapy for the treatment of COPD.

STEM CELL RESEARCH & THERAPY (2021)

Article Medicine, Research & Experimental

Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis

Yong He et al.

Summary: This study reveals that the elevation of miR-223 in hepatocytes is due to preferential uptake of miR-223-enriched EVs released from neutrophils and other cells, mediated by LDLR and APOE expression. The internalized EV-derived miR-223 acts to inhibit hepatic inflammatory and fibrogenic gene expression, thereby limiting the progression of NASH.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Oncology

Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial

Xiaowei Xu et al.

Summary: A study showed that using menstrual blood-derived MSCs to treat severe COVID-19 patients can reduce mortality, improve dyspnea, and increase oxygen saturation levels. This MSC-based therapy may be a promising alternative for treating severe COVID-19.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Biotechnology & Applied Microbiology

Extracellular vesicles derived from hypoxia-preconditioned olfactory mucosa mesenchymal stem cells enhance angiogenesis via miR-612

Lite Ge et al.

Summary: The study revealed that EVs from hypoxic OM-MSCs can enhance angiogenesis through the miR-612-TP53-HIF-1α-VEGF axis, suggesting a promising therapeutic strategy for ischemic diseases.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Immunology

Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities

Susan Moradinasab et al.

Summary: The emergence of novel coronavirus in Wuhan in 2019 has caused a worldwide pandemic, leading to an unprecedented public health crisis. Mesenchymal stromal/stem cells (MSCs) have shown therapeutic potential against COVID-19 due to their immunomodulatory and anti-inflammatory effects, but challenges like malignant transformation and coagulopathy need to be addressed for successful application. Research has shown promising results in the use of MSCs for acute respiratory distress syndrome (ARDS) and viral infections, suggesting MSC therapy could be a valuable approach in treating COVID-19.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Nanoscience & Nanotechnology

Extracellular vesicles as a next-generation drug delivery platform

Inge Katrin Herrmann et al.

Summary: Extracellular vesicles play a crucial role in cell-to-cell communication and can serve as drug carriers with advantages over synthetic carriers. However, clinical translation of extracellular vesicle-based therapies remains challenging, requiring further research and development efforts.

NATURE NANOTECHNOLOGY (2021)

Review Cell & Tissue Engineering

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

Mai Abdelgawad et al.

Summary: MSCs have therapeutic potential in treating COVID-19 by their immunomodulatory and regenerative activities. Clinical studies have shown positive effects of MSCs on the pathophysiology of COVID-19 and cytokine storm. Research also involves the sources, doses, administration, and optimization strategies for MSC-based therapies.

STEM CELL RESEARCH & THERAPY (2021)

Article Medicine, Research & Experimental

Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion

Jinli Ding et al.

Summary: The study revealed that M1 macrophages suppressed trophoblast EMT and reduced their migration and invasion abilities by secreting extracellular vesicles (EVs). miR-146a-5p and miR-146b-5p were identified as the most upregulated miRNAs in trophoblasts treated with M1-EVs, playing a role in inhibiting trophoblast EMT by directly suppressing TNF receptor-associated factor 6 (TRAF6) expression. Aberrant expression of miR-146a-5p, miR-146b-5p, and TRAF6 was found in placental villous tissues from patients with RSA, with negative correlations between miR-146a-5p/miR-146b-5p and TRAF6 expression levels.

THERANOSTICS (2021)

Letter Medicine, General & Internal

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Peter Richardson et al.

LANCET (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Review Respiratory System

Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19

Maroun Khoury et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Allergy

COVID-19: Unanswered questions on immune response and pathogenesis

Enrico Maggi et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Biotechnology & Applied Microbiology

Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections

Wojciech Chrzanowski et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Respiratory System

Pathogenesis of COVID-19-induced ARDS: implications for an ageing population

Manuel A. Torres Acosta et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signaling

Xinxing Zhu et al.

ATHEROSCLEROSIS (2019)

Article Biochemistry & Molecular Biology

MiR-35 buffers apoptosis thresholds in the C. elegans germline by antagonizing both MAPK and core apoptosis pathways

Anh T. Tran et al.

CELL DEATH AND DIFFERENTIATION (2019)

Article Cardiac & Cardiovascular Systems

LncRNA NKILA regulates endothelium inflammation by controlling a NF-kappa B/KLF4 positive feedback loop

Xinxing Zhu et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)

Review Cell & Tissue Engineering

Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

Jacques Galipeau et al.

CELL STEM CELL (2018)

Review Biochemistry & Molecular Biology

Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer

Hongyu Liu et al.

MOLECULAR CANCER (2018)

Article Medicine, Research & Experimental

IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation

Siobhan Smith et al.

JCI INSIGHT (2018)

Review Oncology

MicroRNAs as biomarkers of acute lung injury

Antonio Ferruelo et al.

ANNALS OF TRANSLATIONAL MEDICINE (2018)

Article Cell Biology

Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice

Viola Neudecker et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Critical Care Medicine

Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice

Antoine Monsel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Review Biotechnology & Applied Microbiology

Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications

Sweta Rani et al.

MOLECULAR THERAPY (2015)

Article Cell & Tissue Engineering

The ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p

Gi-Shih Lien et al.

STEM CELL RESEARCH & THERAPY (2014)

Article Biotechnology & Applied Microbiology

Extracellular vesicles: biology and emerging therapeutic opportunities

Samir EL Andaloussi et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Biochemistry & Molecular Biology

Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells

Nobuyoshi Kosaka et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemical Research Methods

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

Margaret S. Ebert et al.

NATURE METHODS (2007)